Dexcom shares plunge more than 40% after Q2 earnings

Dexcom shares sank more than 40% on Friday and headed for their worst day ever after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. The stock fell $45.38 to $62.47 as of early afternoon, wiping out about $18 billion in market cap. Prior to Friday, the biggest drop … Read more

An ugly earnings report from a competitor is good news for Abbott Labs

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Stocks jumped Friday as Wall Street tried to end a turbulent week on a jubilant note. The Dow Jones Industrial Average added more more than 600 points, or 1.6%. The … Read more

Biogen Eisai Alzheimer’s drug Leqembi rejected by European regulator

European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as they scramble to boost uptake of the therapy in the U.S.  The European Commission, the EU’s executive body, has a final say in Leqembi’s approval. But it almost always follows the drug regulator’s recommendations.  … Read more

Bristol Myers Squibb (BMY) earnings Q2 2024

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Friday reported second-quarter earnings and revenue that topped expectations and raised its full-year guidance as the drugmaker moves to slash costs. The pharmaceutical giant raised its … Read more

Dexcom shares plummet more than 30% after company lowers fiscal year guidance

The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Dexcom tumbled more than 33% in after-hours trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. Here’s how the company did: … Read more

GE HealthCare taps Amazon Web Services to build generative AI for medical use

Jakub Porzycki | Nurphoto | Getty Images GE HealthCare on Thursday announced it is teaming up with Amazon Web Services to build new generative artificial intelligence models and tools that can efficiently analyze complex medical data. The health-care industry is responsible for generating nearly one-third of all data globally, but much of this information isn’t … Read more

Viking Therapeutics stock jumps on weight loss injection trial plans

Weight loss drug concept. Cr | Istock | Getty Images Shares of Viking Therapeutics jumped 16% in premarket trading Thursday after the biotech company a day earlier announced plans to advance its experimental weight loss injection into a late-stage trial earlier than expected.  It brings the San Diego-based company one step closer to joining the … Read more

What you need to know as India issues an alert

Fruit bats seen hanging on tree branches in daylight. Bats are believed to be one of the carriers of Nipah virus, a zoonotic disease that spreads from animals to humans. Eyepix Group | Future Publishing | Getty Images Health authorities in the southern Indian state of Kerala are on high alert following the latest flare-up of the … Read more

Pfizer’s gene therapy for hemophilia A succeeds in late-stage trial

Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval. The treatment for hemophilia A could become the company’s second gene therapy to enter the U.S. market after Beqvez, which … Read more

First Medicare drug price negotiations round nears end

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round … Read more